Anagrelide Hydrochloride
Who holds supplier records for Anagrelide Hydrochloride? 8 organisations hold a current record for Anagrelide Hydrochloride: an active US FDA Type II Drug Master File. A further 2 organisations have only historical (inactive) DMF filings. Recorded organisation countries for current records: India (5), France (1) and Latvia (1); not recorded for 1.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records
Cite as: PharmaTek, “Anagrelide Hydrochloride: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/anagrelide-hydrochloride
Reading the evidence
- 8 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
5 of the 7 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 6 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (8)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Anagrelide Hydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.
- ASH STEVENS INCActive DMF 15971 · latest filing May 2002
- CHEMWERTH INCFranceActive DMF 16440 · latest filing Feb 2003
- Cipla LimitedIndia Company GMP cert on recordActive DMF 16024 · latest filing Jun 2002
- MICRO LABS LTDIndia Company GMP cert on recordActive DMF 37180 · latest filing Jun 2022
- OLPHA ASLatvia Company GMP cert on recordActive DMF 17041 · latest filing Dec 2003
- Piramal Pharma LimitedIndia Company GMP cert on recordActive DMF 38181 · latest filing May 2023
- Torrent PharmaceuticalsIndia Company GMP cert on recordActive DMF 29475 · latest filing Jul 2015
- Zydus Lifesciences LimitedIndia Company GMP cert on recordActive DMF 16531 · latest filing Mar 2003
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Historical records (2)
Organisations whose Type II DMFs for Anagrelide Hydrochloride are no longer active. These show a past filing, not current supply.
Show all 2 historical records
- CHEMISCH PHARMAZEUTISCHES LABOR ROLF SACHSE GMBHInactive DMF 18240 · filed Feb 2005
- Italy · Inactive DMF 16969 · filed Nov 2003
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Anagrelide Hydrochloride is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1200759).
Chemical identity
- IUPAC name
- 6,7-dichloro-5,10-dihydro-3H-imidazo[2,1-b]quinazolin-2-one;hydrochloride
- Canonical SMILES
- C1C2=C(C=CC(=C2Cl)Cl)NC3=NC(=O)CN31.Cl
- InChIKey
- TVWRQCIPWUCNMI-UHFFFAOYSA-N
- Synonyms
- Agrelin, Agrylin, Anagrelide hcl, Anagrelide hydrochloride, Anagrelide hydrochloride hydrate, Anagrelide hydrochloride monohydrate, Anagrelide mylan, Anagrelide viatris (previously anagrelide mylan), BL-4162A, BMY-26538-01, NSC-724577, NSC-759170
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Platelet-reducing Agent
- Mechanism of action
- Phosphodiesterase 3 Inhibitors
- Physiologic effect
- Decreased Platelet Production
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Anagrelide Hydrochloride?
8 organisations hold an active US FDA Type II Drug Master File or a CEP for Anagrelide Hydrochloride: ASH STEVENS INC, CHEMWERTH INC (France), Cipla Limited (India), MICRO LABS LTD (India), OLPHA AS (Latvia), Piramal Pharma Limited (India), Torrent Pharmaceuticals (India) and Zydus Lifesciences Limited (India). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Anagrelide Hydrochloride Drug Master Files are active?
ASH STEVENS INC (DMF 15971), CHEMWERTH INC (DMF 16440), Cipla Limited (DMF 16024), MICRO LABS LTD (DMF 37180), OLPHA AS (DMF 17041), Piramal Pharma Limited (DMF 38181), Torrent Pharmaceuticals (DMF 29475) and Zydus Lifesciences Limited (DMF 16531). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Anagrelide Hydrochloride records mean?
2 organisations have only inactive Type II DMFs for Anagrelide Hydrochloride. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
How do I qualify a Anagrelide Hydrochloride supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Anagrelide Hydrochloride?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.